Developing Artificial Intelligence-based Precision Therapeutics for Patients with Autoimmune and Chronic Inflammatory Diseases
Athos Therapeutics Inc. is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Athos Therapeutics Innovative Drug Discovery & Development Platform
Athos has developed a unique platform able to identify and develop novel drugs for patients with autoimmune and chronic inflammatory diseases. This approach is based on the integration of medicinal chemistry and systems biology through machine learning.
Taken together these two approaches, combined with a machine learning algorithm, identify the best compounds that safely and efficiently target key disease factors.
- First, we identify novel factors related to the disease pathobiology based on the integration of human clinical and molecular datasets from patients with autoimmune diseases.
- Second, we synthesize small molecules based on our computational medicinal chemistry platform.
Taken together these two approaches, combined with a machine learning algorithm, identify the best compounds that safely and efficiently target key disease factors.
